Knight Therapeutics | GUD - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 7M 2M 2026-03
Aurora Cannabis CAD 193.82M 133.39M 2026-03
Avita Medical AUD 105.47M 35.32M 2025-12
Canopy Growth CAD 557.13M 99.33M 2026-03
Cronos Group USD 958.02M 45.05M 2026-03
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
IQVIA Holdings USD 32.25B 3.62B 2026-06
Organigram Holdings CAD 252.47M 59.69M 2026-03
Organon & Co USD 1.57B 290M 2026-03
Revvity USD 9.94B 1.03B 2026-03
Tectonic Therapeutic USD 580M 190M 2026-03
Viatris USD 15.73B 1.39B 2026-03
Xeris Pharmaceuticals USD 1000M 303M 2026-03